Document is current
Any future updates will be listed below
-
Authors
Cordoba-Melo, Brayan Daniel https://orcid.org/0000-0003-2401-6413
Seni-Molina, Sebastián https://orcid.org/0009-0006-2151-0722
Arango-Ibanez, Juan Pablo https://orcid.org/0000-0003-3601-3279
Ayala, Milton René https://orcid.org/0000-0003-3458-4246
Tatis-Méndez, José Fidel https://orcid.org/0009-0009-3097-2234
Quintero Yepez, Viviana https://orcid.org/0000-0001-8193-6369
Mejía Cadavid, Luz Aída https://orcid.org/0000-0001-8201-0322
Cruz-Cuevas, José D. https://orcid.org/0000-0003-4593-6155
Ariza-Ordóñez, Nicolás https://orcid.org/0000-0003-4137-8774
Buitrago, Andrés https://orcid.org/0000-0001-7693-0771
Lopez-Lopez, Jose Patricio https://orcid.org/0000-0001-8865-0929
Hinestrosa, Alfredo
Sabogal, Jorge
Reyes-Vargas, Cristian
Herrera-Escandon, Álvaro https://orcid.org/0000-0001-6891-1837
Hurtado, Juan Sebastián
Velásquez Osorio, Juan Fernando https://orcid.org/0009-0003-7510-2132
Londoño, Sergio
Salamanca, Carlos
Vallecilla, Liliana https://orcid.org/0000-0002-5946-2408
Leon-Giraldo, Hoover https://orcid.org/0000-0002-8854-105X
Ruiz, Alvaro J. https://orcid.org/0000-0001-6528-4268
Molina, Dora Inés https://orcid.org/0000-0002-8006-915X
Gomez-Mesa, Juan Esteban https://orcid.org/0000-0002-6635-6224
,
- License Information
-
More Information
Article History
Received: 15 May 2025
Accepted: 30 June 2025
First Online: 2 September 2025
Declarations
:
: The study is conducted in accordance with the principles outlined in the Declaration of Helsinki []. The study protocol was approved by the ethics committees of each participating center and was classified as minimal risk in accordance with Resolution 8430 of 1993 from the Colombian Ministry of Health. Informed consent was not required due to the study’s retrospective design and minimal risk classification. The study protocol was approved by the Comité de Ética en Investigación Biomédica of Fundación Valle del Lili (approval number: 2023.2124) and was classified as minimal risk under Resolution 8430 of 1993 from the Colombian Ministry of Health. Additionally, the protocol was submitted to and approved by the ethics committees of all participating centers. Informed consent was not required due to the retrospective design of the study and its classification as minimal risk.
: Not applicable.
: Two authors of this study, S.L. and C.S., are Sanofi employees and may hold shares and/or stock options in the company; however, their participation in this research does not represent the interests of their institution. The funding organization had no role in the study design, data collection, analysis, interpretation, or manuscript preparation. The remaining authors declare that they have no competing interests.
